M6620 (VX-970)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for M6620 (VX-970), covering 2022-10-25 to 2022-10-25. Get the full timeline:
Most recent: Clinical Trial Update: Gemcitabine Hydrochloride Alone or With M6620 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 2]